Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1766249

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1766249

U.S. Electrocardiogram (ECG) Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

PUBLISHED:
PAGES: 60 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2550
PDF & Excel (Multi User License)
USD 3750
PDF & Excel (Enterprise User License)
USD 5050

Add to Cart

U.S. Electrocardiogram Devices Market was valued at USD 2.4 billion in 2024 and is estimated to grow at a CAGR of 6.1% to reach USD 4.3 billion by 2034. The rising prevalence of cardiovascular conditions such as coronary artery disease, arrhythmias, and heart attacks continues to pose a serious health challenge across the nation. This long-standing issue has significantly elevated the demand for ECG devices, which play a crucial role in identifying and managing heart disorders early. The growing adoption of ECG equipment across hospitals, outpatient care centers, and emergency departments highlights a broader shift in the U.S. healthcare system toward prevention and personalized care.

U.S. Electrocardiogram (ECG) Devices Market - IMG1

An aging population also plays a pivotal role, with seniors requiring more frequent cardiac monitoring as they face higher risks of heart failure and other chronic conditions. Technologies like wearable and home-use ECG devices are now integral in managing long-term heart health and reducing the need for repeated hospital visits. These tools offer real-time tracking and timely alerts, supporting better outcomes and improving quality of life. As innovation drives enhanced access and utility, the ECG market is experiencing a notable transformation that aligns with current healthcare priorities and patient expectations.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$2.4 billion
Forecast Value$4.3 billion
CAGR6.1%

In 2024, diagnostic ECG machines accounted for a 62.7% share, making it the top-performing segment. These devices remain essential in clinical settings by enabling providers to detect and assess cardiac conditions such as heart rhythm abnormalities and heart attacks. Their importance is especially pronounced in emergency rooms and primary care environments, where early recognition of heart issues can influence both treatment choices and patient survival. Demand is consistently rising as cardiovascular disease remains a primary cause of death in the U.S., further emphasizing the need for reliable diagnostic tools that can deliver accurate, rapid results.

The portable ECG devices segment led the market with a revenue of USD 1.4 billion in 2024. The shift toward decentralized care models and patient-focused services has fueled the growth of this segment. These mobile solutions are becoming indispensable as they allow continuous and convenient heart monitoring outside of traditional clinical spaces. Whether used for chronic condition tracking, preventive assessments, or emergency response, portable ECG units help ensure faster care delivery. They are particularly valuable within outpatient frameworks, enabling earlier diagnosis and proactive treatment while minimizing unnecessary hospital visits. Their flexibility and efficiency are expected to continue driving strong market expansion in the years ahead.

U.S. Northeast Electrocardiogram (ECG) Devices Market generated USD 412.3 million in 2024 to USD 710.6 million by 2034. This region benefits from a strong digital health infrastructure, a mature healthcare system, and a growing elderly population. The swift adoption of wearable and home-based ECG solutions across states in the Northeast is enhancing chronic care management and enabling faster detection of cardiac abnormalities. These advancements support more timely interventions, which are particularly critical for high-risk and older individuals. As healthcare providers prioritize early diagnosis and continuous monitoring, this region is set to witness rapid expansion in ECG device usage.

Prominent companies operating in the U.S. Electrocardiogram (ECG) Devices Market include Medtronic, OSI Systems, Nihon Kohden, AliveCor, Bionet Co., BIOTRONIK, GE HealthCare Technologies, Philips, Baxter International, BPL Medical Technologies, Cardioline, Mindray, Schiller, Biotricity, Allengers, Boston Scientific, and Fukuda Denshi. To reinforce their foothold in the U.S. Electrocardiogram (ECG) Devices Market, leading companies are emphasizing innovation, integration, and strategic expansion. Many are investing in R&D to develop smarter, wireless ECG technologies that support remote diagnostics and real-time patient monitoring.

Partnerships with healthcare providers and digital health platforms are enabling smoother integration into clinical workflows. Key players are also expanding their product lines to cater to the growing demand for wearable and portable solutions. Additionally, companies are leveraging AI and machine learning to enhance diagnostic accuracy and user experience. Collaborations, mergers, and regional distribution expansion remain central to increasing market penetration. These strategies allow brands to meet the evolving needs of hospitals, clinics, and home care providers while staying competitive.

Product Code: 14084

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 By product
    • 2.2.2 By lead type
    • 2.2.3 By portability
    • 2.2.4 By end use
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of Age-Related Macular Degeneration (AMD)
      • 3.2.1.2 Growth in aging population
      • 3.2.1.3 Advancements in treatment options
      • 3.2.1.4 Increased awareness and early diagnosis
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of treatment
      • 3.2.2.2 Risk of complications from intravitreal injections
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Expansion of Portable, Wearable, and Remote Monitoring Solutions
      • 3.2.3.2 Rising Demand Due to Increasing Cardiovascular Disease Prevalence and Aging Population
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By lead type
    • 3.3.3 By portability
    • 3.3.4 By end use
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Value chain analysis
  • 3.11 Overview on usefulness of wearable ECG devices in patients experiencing paroxysmal cardiac-related symptoms
  • 3.12 Development of a handheld electrocardiogram device in a clinical setting
  • 3.13 Development of flexible wearable electrodes for electrocardiogram monitoring during exercise

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
    • 4.1.1 GE HealthCare Technologies
    • 4.1.2 Koninklijke Philips
    • 4.1.3 Baxter International
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 U.S. Electrocardiogram (ECG) devices market share analysis
    • 4.3.2 12-lead type company share analysis
      • 4.3.2.1 Manufacturer level
      • 4.3.2.2 Model level
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostics ECG machines
    • 5.2.1 Resting ECG
    • 5.2.2 Stress ECG
  • 5.3 Monitoring ECG devices
    • 5.3.1 Holter monitoring
    • 5.3.2 ECG telemetry monitoring/Event monitoring
    • 5.3.3 Implantable cardiac monitors
    • 5.3.4 Other monitoring ECG devices

Chapter 6 Market Estimates and Forecast, By Lead Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 12 lead type
  • 6.3 6 lead type
  • 6.4 Single lead type
  • 6.5 3 lead type
  • 6.6 Other lead types

Chapter 7 Market Estimates and Forecast, By Portability, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Portable device
  • 7.3 Non-portable device

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Ambulatory surgical centers
  • 8.4 Diagnostic centers
  • 8.5 Home care settings
  • 8.6 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 South Atlantic
  • 9.3 North East
  • 9.4 East North Central
  • 9.5 Pacific Central
  • 9.6 West South Central
  • 9.7 West North Central
  • 9.8 Mountain States
  • 9.9 East South Central

Chapter 10 Company Profiles

  • 10.1 AliveCor
  • 10.2 Allengers
  • 10.3 Baxter International
  • 10.4 Bionet Co.
  • 10.5 Biotricity
  • 10.6 BIOTRONIK
  • 10.7 Boston Scientific
  • 10.8 BPL Medical Technologies
  • 10.9 Cardioline
  • 10.10 Fukuda Denshi
  • 10.11 GE HealthCare Technologies
  • 10.12 Koninklijke Philips
  • 10.13 Medtronic
  • 10.14 Mindray
  • 10.15 Nihon Kohden
  • 10.16 OSI Systems
  • 10.17 Schiller
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!